PMC:7299399 / 1874-2017
Annnotations
LitCovid-PD-FMA-UBERON
{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T49319","span":{"begin":34,"end":42},"obj":"Body_part"}],"attributes":[{"id":"A28884","pred":"fma_id","subj":"T49319","obj":"http://purl.org/sig/ont/fma/fma84050"}],"text":"ARS-CoV-2 or in counteracting the cytokine storm, respectively. In addition to disease prevention and therapeutic potential, nanotechnology has"}
LitCovid-PD-CLO
{"project":"LitCovid-PD-CLO","denotations":[{"id":"T30007","span":{"begin":140,"end":143},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"ARS-CoV-2 or in counteracting the cytokine storm, respectively. In addition to disease prevention and therapeutic potential, nanotechnology has"}
LitCovid-PD-HP
{"project":"LitCovid-PD-HP","denotations":[{"id":"T1","span":{"begin":34,"end":48},"obj":"Phenotype"}],"attributes":[{"id":"A1","pred":"hp_id","subj":"T1","obj":"http://purl.obolibrary.org/obo/HP_0033041"}],"text":"ARS-CoV-2 or in counteracting the cytokine storm, respectively. In addition to disease prevention and therapeutic potential, nanotechnology has"}